| Literature DB >> 36009212 |
Xue Yu1,2,3, Kan Jiang4, Wei Zhang1,2, Shuqing Dong5, Yujie Wu2,3,6, Gaosen Zhang2,6, Shiyu Wu2, Tuo Chen2,6, Guangxiu Liu1,2.
Abstract
The genus Arthrobacter is a source of many natural products that are critical in the development of new medicines. Here, we isolated a novel carotenoid from Arthrobacter sp. QL17 and characterized its properties. The carotenoid was extracted with methanol, and purified by column chromatography and semi-preparative HPLC. Based on micrOTOF-Q and NMR analyses, the pigment was chemically characterized as 2,2'-((((1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,14,18-tetramethylicosa-1,3,5,7,9,11,13,15,17,19-decaene-1,20-diyl)bis(2,2,4-trimethylcyclohex-3-ene-3,1-diyl)) bis(ethan-2-yl-1-ylidene))bi(propane-1,3-diol), and named arthroxanthin. The biological activities of arthroxanthin were evaluated with DPPH, ABTS and MTT assays. Arthroxanthin exhibited excellent radical scavenging properties, as shown for 2, 20-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-n-(3,2-ethyl-benzothiazole-6-sulfonic acid) ammonium salt (ABTS), respectively, with IC50s of 69.8 and 21.5 µg/mL. It also showed moderate anticancer activities against HepG2, Hela, MDAB-231, SW480, and MKN-45 with IC50 values of 107.6, 150.4, 143.4, 195.9, and 145.5 μg/mL, respectively. Therefore, arthroxanthin derived from Arthrobacter sp. QL17 may be a potent antioxidant and anticancer agent for food and pharmaceutical use.Entities:
Keywords: Arthrobacter; anticancer; antioxidant; carotenoid
Year: 2022 PMID: 36009212 PMCID: PMC9404904 DOI: 10.3390/antiox11081493
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1(a) A phylogenetic tree based on 16S rRNA gene sequence, and (b) colonies on R2A medium and liquid culture of Arthrobacter sp. QL17.
Figure 2Survival rate of QL17 and E. coli stressed by the H2O2. Error bars represent standard deviation of the mean (n = 3); p < 0.05.
Figure 3Purification and structural identification of arthroxanthin produced by QL17. (a) HPLC analysis of arthroxanthin. (b) MicrOTOF-Q analysis of arthroxanthin.
NMR spectroscopic data for the arthroxanthin.
| Position |
|
| Position |
|
|
|---|---|---|---|---|---|
| 1,1′ | 3.62 * | 71.2,72.9 | 14,14′ | 6.68 | 131.6 |
| 2,2′ | 138.9 | 15,15′ | 6.68 | 129.6 | |
| 3,3′ | 5.48 | 124.6 | 16,16′ | 138.3 | |
| 4,4′ | 1.92 | 27.2 | 17,17′ | 6.41 | 125.3 |
| 5,5′ | 1.77 | 42.7 | 18,18′ | 6.68 | 133.1 |
| 6,6′ | 1.55 | 29.7 | 19,19′ | 6.68 | 130.5 |
| 7,7′ | 1.99 | 29.9 | 20,20′ | 138.2 | |
| 8,8′ | 134.7 | 21,21′ | 6.29 | 125.3 | |
| 9,9′ | 133.3 | 22,22′ | 6.29 | 131.6 | |
| 10,10′ | 29.4 | 23,23′ | 6.29 | 129.6 | |
| 11,11′ | 1.21 | 24.5 | 24,24′ | 1.98 | 13.1 |
| 12,12′ | 1.21 | 24.5 | 25,25′ | 1.98 | 13.0 |
| 13,13′ | 1.93 | 13.3 |
The assignments were based on 1H-1H COSY, HSQC, and HMBC experiments. * this signal peak is determined by the HSQC spectrum.
Figure 4(a) DPPH radical scavenging activity of arthroxanthin. (b) ABTS radical scavenging activity of arthroxanthin. (c) IC50 values of β-carotene and arthroxanthin in different radical scavenging activity assays. *** p < 0.001 compared with β-carotene.
Figure 5Effect of arthroxanthin on the cell viability of various cancer types. (a) Cancerous cells were incubated with different concentrations of arthroxanthin (0–500 µg/mL) for 48 h. Then, cell viability (%) was assessed by an MTT assay. (b) Cancerous cells were incubated with different concentrations of β-carotene (0–500 µg/mL) for 48 h. (c) IC50 values of β-carotene and arthroxanthin against cancerous cells at 48 h. *** p < 0.001 compared with β-carotene.